• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,983.18 64.42
( 0.09%)
Global Indices
Nasdaq
50,884.98 77.97
(0.15%)
Dow Jones
7,407.31 -19.42
(-0.26%)
Hang Seng
64,234.22 -1,182.41
(-1.81%)
Nikkei 225
10,242.24 -130.96
(-1.26%)
Forex
USD-INR
95.53 0.30
(0.32%)
EUR-INR
110.14 0.47
(0.43%)
GBP-INR
127.43 0.45
(0.36%)
JPY-INR
0.60 0.00
(0.41%)

EQUITY - MARKET SCREENER

Hemo Organic Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
524590
INE422G01015
-2.6951153
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
7.72
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

cinevista ltd
Hester Biosciences consolidated net profit rises 1138.76% in the March 2026 quarter
May 15,2026
Net profit of Hester Biosciences rose 1138.76% to Rs 15.98 crore in the quarter ended March 2026 as against Rs 1.29 crore during the previous quarter ended March 2025. Sales rose 22.19% to Rs 100.11 crore in the quarter ended March 2026 as against Rs 81.93 crore during the previous quarter ended March 2025.

For the full year,net profit rose 102.40% to Rs 55.64 crore in the year ended March 2026 as against Rs 27.49 crore during the previous year ended March 2025. Sales rose 6.91% to Rs 332.60 crore in the year ended March 2026 as against Rs 311.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales100.1181.93 22 332.60311.10 7
OPM %34.2923.41 -26.0619.63 -
PBDT28.067.92 254 91.7856.37 63
PBT22.153.75 491 72.9039.57 84
NP15.981.29 1139 55.6427.49 102